These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5784519)

  • 1. [On the hormonal prevention of dyshormonal hyperplasia of the mammary glands in mice].
    Dmitriev VN
    Vopr Onkol; 1969; 15(1):59-61. PubMed ID: 5784519
    [No Abstract]   [Full Text] [Related]  

  • 2. [The similarity of the pathogenesis of dyshormonal mammary gland changes in mice under various conditions].
    Dmitriev VN
    Vopr Onkol; 1971; 17(2):59-62. PubMed ID: 5567710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thermography in detecting breast diseases in mass prophylactic examinations].
    Lindenbraten LD; Ginzburg LI
    Med Tekh; 1980; (4):49-52. PubMed ID: 7402041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of infecundin in dyshormonal hyperplasia of the breast associated with ovarian dysfunction].
    Mezinova NN
    Sov Med; 1975 Jun; (6):85-90. PubMed ID: 1162479
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cytomorphologic characteristics of dyshormonal hyperplasia of the mammary glands].
    Koriakina RF
    Lab Delo; 1969; 10():628-32. PubMed ID: 4193063
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.
    Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL
    Cancer Res; 1996 Jul; 56(14):3180-5. PubMed ID: 8764102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the treatment of dyshormonal hyperplasia of mammary glands].
    Vishniakova VV; Murav'eva NI
    Vestn Akad Med Nauk SSSR; 1966; 21(9):19-22. PubMed ID: 5999442
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of benz[a]pyrene-induced mammary carcinogenesis by retinyl acetate.
    McCormick DL; Burns FJ; Albert RE
    J Natl Cancer Inst; 1981 Mar; 66(3):559-64. PubMed ID: 6970847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined prophylactic examinations of women in detecting early stages of breast cancer and precancerous conditions].
    Ismaĭlov AKh
    Klin Khir (1962); 1983 May; (5):26-7. PubMed ID: 6876579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyshormonal hyperplasia of the mammary glands of guinea pigs. (On the problem of species specificity in the reaction to hormonal influences)].
    ZHURAVLEVA TB
    Arkh Patol; 1961; 23(3)():43-50. PubMed ID: 13788387
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of tamoxifen on the breast cancer risk induced by exogenous estrogen in rat].
    Zeng X; Yao Z
    Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):176-9. PubMed ID: 9387675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene control of neoplasia. I. Genotypic mosaicism in normal and preneoplastic mammary glands of allophenic mice.
    Mintz B; Slemmer G
    J Natl Cancer Inst; 1969 Jul; 43(1):87-109. PubMed ID: 5796398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiology of dyshormonal diseases and malignant tumors of the breast].
    Ismaĭlov AKh
    Khirurgiia (Mosk); 1986 Sep; (9):31-3. PubMed ID: 3795806
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Wood C; Cline M
    J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of the cis-aconitic acid for the biological inactivation of the 3,4-benzopyrene cancerogenesis (author's transl)].
    Kallistratos G
    Experientia; 1975 Apr; 31(4):490-1. PubMed ID: 1120532
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.
    Ethier SP; Ullrich RL
    Cancer Res; 1982 May; 42(5):1753-60. PubMed ID: 6802483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The description and problem of true "adenosis" of the mammary gland, with its frequency and relations of interdependence with fibrocystic mastopathy].
    Grechi G; Mincione G; Riggi F
    Arch De Vecchi Anat Patol; 1966 Aug; 47(3):753-84. PubMed ID: 5987397
    [No Abstract]   [Full Text] [Related]  

  • 20. Murine mammary tumor virus expression during mammary tumorigenesis in ICRC mice.
    Chiplunkar SV; Karande KA
    Neoplasma; 1983; 30(2):137-46. PubMed ID: 6302528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.